Keros Therapeutics, Inc. (KROS)

16.28 -0.27 (-1.63%) USD  |  NASDAQ  |  Feb 20, 13:35
More

Keros Therapeutics Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
MannKind Corp. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Insmed, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade